BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CYP51
,
Fatty acid metabolic process
,
Lung cancer
,
Heart
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptor- TP
Summary
General Info
Curated Studies
Most Correlated Studies
Lung cancer A549 cells with shRNA-mediated AXL knockdown or treated with AXL inhibitor TP-0903
Multiple myeloma cells treated with A2A and Beta-2 Adrenergic Receptor agonists with dexamethasone
Breast cancer cells expressing phosphorylated or sumoylation-deficient progesterone receptor
Liver biopsies from chronic hepatitis B patients treated with IFNA1
Breast cancer T-47D cells overexpressing PGR-B, G2/M phase synchronized, and treated with R-5020
Explore Curated Studies Results
Literature
Most Relevant Literature
Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways b…
Comparative study on the effect of aspirin, TP receptor antagonist and TxA2 synthase inhibitor on th…
Role of thromboxane receptor in C-reactive protein-induced thrombosis.
Isoprostanes evoke contraction of the murine and human detrusor muscle via activation of the thrombo…
Prostanoid TP receptor stimulation enhances contractile activities in guinea pig urinary bladder smo…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer
Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NS…
Clinical Trial Comparing Noradrenaline (NA) Plus Placebo Versus Noradrenaline Plus Terlipressin (TP)…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ